Real-time enrollment status for this castration-resistant prostate cancer (crpc) clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 10:35 AM UTC
| NCT Number | NCT07189871 |
| Recruiting Status | Recruiting |
| Condition | Castration-Resistant Prostate Cancer (CRPC) |
| Phase | PHASE1 |
| Target Enrollment | 61 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Radiopharm Theranostics, Ltd |
| Last Updated on CT.gov | October 1, 2026 (2 weeks ago) |
As of October 16, 2026: Clinical trial NCT07189871 is currently recruiting participants. This phase1 study for castration-resistant prostate cancer (crpc) is actively seeking new participants at 5 locations across the United States. The study is sponsored by Radiopharm Theranostics, Ltd. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07189871 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07189871 was last updated 2 weeks ago (October 1, 2026). HelloStudys verifies this status automatically.